Related Experiment Videos
Development of cardiac failure by coronary small vessel disease in hypertensive heart disease?
1Medical Clinic and Policlinic B, University of Düsseldorf, Germany.
Insights
Essential hypertension impairs ventricular function through myocardial hypertrophy and coronary artery issues. Coronary small vessel disease is a key factor in developing cardiac failure in hypertensive heart disease.
Area of Science:
- Cardiology
- Hypertension Research
- Pathophysiology
Background:
- Essential hypertension significantly impacts cardiac structure and function.
- Ventricular function is influenced by myocardial hypertrophy and coronary artery complications.
- Hypertensive heart disease is a prevalent condition linked to increased cardiovascular risk.
Purpose of the Study:
- To investigate the mechanisms underlying ventricular dysfunction in essential hypertension.
- To explore the role of myocardial hypertrophy and coronary factors in hypertensive heart disease.
- To identify underlying mechanisms for cardiac failure in the context of hypertension.
Main Methods:
- Analysis of ventricular function in relation to hypertrophy and coronary artery status.
- Assessment of myocardial compliance, systolic wall stress, and ventricular size.
- Morphological and functional evaluation of coronary resistance vessels and myocardial tissue.
Main Results:
- Ventricular function is inversely correlated with ventricular size and systolic wall stress.
- Coronary reserve is limited in hypertensive individuals, even without significant stenosis.
- Pressure-dependent vascular hypertrophy and impaired oxygen supply contribute to myocardial damage and diastolic dysfunction.
- Coronary small vessel disease is identified as a primary mechanism for cardiac failure in hypertensive heart disease.
Conclusions:
- Coronary small vessel disease is a critical determinant of cardiac failure in essential hypertension.
- Myocardial hypertrophy and impaired coronary function are key contributors to ventricular dysfunction.
- Understanding these mechanisms is crucial for managing hypertensive heart disease and preventing cardiac failure.
Abstract:
In essential hypertension, ventricular function is determined primarily by the degree of hypertrophy (myocardial factor) and by organic complications in the coronary artery (coronary factor). Ventricular function is inversely correlated with ventricular size and systolic wall stress, inasmuch as ventricular function diminishes when these two variables increase. Even the young hypertensive heart of normal size with no angiographic abnormalities appears to be prone to ischemia, because the coronary reserve is seriously limited even in the absence of coronary stenosis. Unlike ventricular distensibility, myocardial compliance may be normal, even in the presence of pronounced myocardial hypertrophy. As myocardial compliance decreases, systolic wall stress increases and ventricular function is reduced. The hypertensive heart, the most common form of an irregular hypertrophy of the ventricular wall, is found in 14% of such cases. Analysis of the degree of hypertrophy shows that the hypertrophy can be inappropriately high (high mass-to-volume ratio, reduced wall stress), appropriate, or inappropriately low (normal mass-to-volume ratio, increased wall stress). One of the profound mechanisms influencing both myocardial and coronary function in hypertensive heart disease is the pressure-dependent development of smooth vascular hypertrophy (media) or coronary resistance vessels. Consequently, the oxygen supply to the myocardium is impaired and secondary lesions occur such as fibrosis, increased myocardial and perivascular collagen content and scars within the heart muscle. Diastolic dysfunction develops, as well as an increase in myocardial stiffness, thus promoting the transition from the concentric (compensated) to the eccentric or dilated (decompensated) state, with the consequence of the occurrence of cardiac failure. On the basis of both functional and morphological criteria, evidence is presented in this report that coronary small vessel disease is one of the underlying mechanism for the development of cardiac failure in hypertensive heart disease.